Calloway’s Nursery – CLWY

Calloway’s Nursery operates 18 garden center stores in the Dallas-Fort Worth and Houston, Texas areas. The company has been in operation since 1987. I ran across Calloway’s on Nate Tobik of Oddballstocks.com’s excellent site unlistedstocks.net, a great resource for financial information on these overlooked companies. Calloway’s is tiny, with a market capitalization of $6 million …

Continue reading ‘Calloway’s Nursery – CLWY’ »

Advant-e Cancels Reverse Split, Declares Special Dividend – ADVC

Canceled Reverse Split In a surprising turn of events, Advant-e has announced it will not proceed with its planned 1 for 10,000 reverse stock split. This is excellent news for small shareholders, who will no longer be forcibly cashed out at a large discount to fair value. Advant-e cited delays in regulatory review and approval, …

Continue reading ‘Advant-e Cancels Reverse Split, Declares Special Dividend – ADVC’ »

ACME Communications Completes Station Sale, Announces Distribution – ACME

Today ACME Communications announced the closing of its New Mexico TV stations to Tamer Media and Lin Media. The company announced a $0.93 distribution to shareholders of record as of December 14 to be paid on December 21. The distribution will be treated entirely as a return of capital. After the distribution, ACME Communications will …

Continue reading ‘ACME Communications Completes Station Sale, Announces Distribution – ACME’ »

Unlisted Companies Join the Special Dividend Parade

The past several weeks have seen a flood of companies announce special dividends in advance of almost certainly higher tax rates to come in 2013. While perhaps less noticed by the financial community, unlisted companies have been active participants in the trend. I compiled a short list of non-financial companies that have declared special dividends …

Continue reading ‘Unlisted Companies Join the Special Dividend Parade’ »

Repro-Med Systems: Growth and More Growth – REPR

Repro-Med Systems sells the FREEDOM60® Syringe Infusion System as well as other medical devices. The company is profitable and has grown revenues at 29.6% annually since 2006. Repro-Med was co-founded in 1980 by CEO Andrew I. Sealfon, who owns 21% of shares outstanding. Repro-Med’s flagship product is the FREEDOM60® Syringe Infusion System. This device allows …

Continue reading ‘Repro-Med Systems: Growth and More Growth – REPR’ »